OR13Z2P

Across TCGA pan-cancer cohorts, OR13Z2P RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of OR13Z2P’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where OR13Z2P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR13Z2P is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

BLCA, UCEC, and HNSC are the cancer types where OR13Z2P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR13Z2P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	III,IV	+0.172	<.001	9	view →
UCEC	All	IV	+0.730	.002	8	view →
HNSC	All	All	+0.051	<.001	8	view →
STAD	All	All	+0.234	<.001	7	view →
LUSC	All	All	+0.179	<.001	5	view →
LIHC	All	All	+0.097	<.001	5	view →
LUAD	Female	All	+0.267	<.001	4	view →
CHOL	All	II,III,IV	+1.305	.017	2	view →
PAAD	Female	All	+0.285	.002	2	view →
BRCA	All	All	+0.049	.014	2	view →
PRAD	All	All	+0.046	.033	2	view →
READ	All	All	+0.181	.048	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

OR13Z2P–BLCA

Open the BLCA breakdown →